BMY
Bristol-Myers Squibb Company
62.60$
-0.7%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.3% | +17.3% | +6.9% | +8.6% | +15.9% | +62.6% | +9.1% | -0.5% | -2.5% | +7.3% | -0.2% | |
| – | -3.2% | +31.4% | +18.0% | +11.5% | +37.1% | +134.0% | -5.7% | +0.2% | -0.1% | +6.2% | -33.2% | |
| – | +6.7% | +13.2% | +3.2% | +7.5% | +7.3% | +25.8% | +23.3% | -1.0% | -4.3% | +8.2% | +24.9% | |
| – | -0.1% | +9.1% | +12.8% | +3.3% | +15.9% | +60.6% | -0.3% | -1.3% | -2.2% | +6.2% | +1.7% | |
| – | -81.8% | -43.1% | +78.0% | +2,709.3% | +7.0% | +57.3% | +0.4% | +1.6% | -19.6% | +1.4% | -11.1% | |
| – | +0.0% | +5.1% | +4.3% | -0.4% | +11.7% | +59.2% | +0.1% | 0.0% | -1.9% | +5.3% | +15.5% | |
| – | +25.6% | +31.5% | +1.2% | +22.0% | +0.7% | -30.2% | +112.4% | -2.8% | -8.6% | +14.0% | +42.1% | |
| – | -9.4% | -9.2% | +17.4% | -6.6% | +258.5% | +116.5% | -6.1% | -7.6% | -5.4% | +67.0% | -2.9% | |
| – | -12.8% | +184.8% | -13.3% | +16.3% | -16.6% | -238.1% | – | -4.8% | +9.4% | -199.3% | – | |
| – | +26.7% | +215.7% | +195.2% | -75.4% | +48.4% | +40.2% | -49.0% | +26.2% | -70.8% | +38.5% | +310.1% | |
| – | -21.9% | +184.8% | -77.4% | +388.6% | -30.1% | -361.6% | – | -9.5% | +26.8% | -211.5% | – | |
| – | -13.6% | +145.1% | -5.4% | +11.0% | +8.7% | -33.2% | +308.2% | -4.5% | +0.8% | -83.6% | +380.7% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.